P2–397: Safety and tolerability of rosiglitazone (RSG) in patients with mild to moderate Alzheimer's disease (AD)

Authors :: Suzanne Craft
Allen D. Roses
Ian Foley
Jill F.B. Altman
Ann M. Saunders
George C. Ormandy
Marina Zvartau-Hind
David A. Hosford
Marc E. Risner
Source :: Alzheimer's & Dementia. 2
Publication Year :: 2006
Publisher :: Wiley, 2006.

Subjects :: medicine.medical_specialty
Epidemiology
business.industry
Health Policy
Disease
Gastroenterology
Psychiatry and Mental health
Cellular and Molecular Neuroscience
Developmental Neuroscience
Tolerability
Internal medicine
medicine
In patient
Neurology (clinical)
Geriatrics and Gerontology
Rosiglitazone
business
medicine.drug

Full Text Access

Tools